본문으로 건너뛰기
← 뒤로

Directions in Nonmelanocytic Tumors: Squamous Cell Carcinoma and Merkel Cell Carcinoma.

1/5 보강
Dermatologic clinics 📖 저널 OA 0% 2021: 0/2 OA 2022: 0/1 OA 2024: 0/2 OA 2025: 0/4 OA 2026: 0/10 OA 2021~2026 2026 Vol.44(2) p. 221-231
Retraction 확인
출처

Elsensohn A

ℹ️ 이 논문은 무료 전문이 아직 없습니다. 코퍼스 전체의 43.8%는 무료 가능 (통계 →) · 🏥 기관 EZproxy로 시도

📝 환자 설명용 한 줄

Refinements in histologic criteria, staging systems (American Joint Committee on Cancer 8th edition, Brigham and Women's Hospital), clinical guidelines (National Comprehensive Cancer Network [NCCN]),

이 논문을 인용하기

↓ .bib ↓ .ris
APA Elsensohn A (2026). Directions in Nonmelanocytic Tumors: Squamous Cell Carcinoma and Merkel Cell Carcinoma.. Dermatologic clinics, 44(2), 221-231. https://doi.org/10.1016/j.det.2026.01.008
MLA Elsensohn A. "Directions in Nonmelanocytic Tumors: Squamous Cell Carcinoma and Merkel Cell Carcinoma.." Dermatologic clinics, vol. 44, no. 2, 2026, pp. 221-231.
PMID 41951324 ↗

Abstract

Refinements in histologic criteria, staging systems (American Joint Committee on Cancer 8th edition, Brigham and Women's Hospital), clinical guidelines (National Comprehensive Cancer Network [NCCN]), and molecular tools like gene expression profiling have enhanced the precision of cutaneous squamous cell carcinoma diagnosis and treatment. In Merkel cell carcinoma, recent updates in viral pathogenesis, immunohistochemistry, and emerging biomarkers have aided in better diagnostics. As immunotherapies and precision oncology evolve, dermatopathologists remain essential in guiding patient-specific management strategies for both cutaneous squamous cell carcinoma and Merkel cell carcinoma.

🏷️ 키워드 / MeSH 📖 같은 키워드 OA만

🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반